These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 24942865

  • 1. Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3.
    Jin Q, Lee HJ, Min HY, Smith JK, Hwang SJ, Whang YM, Kim WY, Kim YH, Lee HY.
    Carcinogenesis; 2014 Oct; 35(10):2232-43. PubMed ID: 24942865
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM.
    Cancer Res; 2002 Jun 15; 62(12):3530-7. PubMed ID: 12068000
    [Abstract] [Full Text] [Related]

  • 3. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
    Cortés-Sempere M, de Miguel MP, Pernía O, Rodriguez C, de Castro Carpeño J, Nistal M, Conde E, López-Ríos F, Belda-Iniesta C, Perona R, Ibanez de Caceres I.
    Oncogene; 2013 Mar 07; 32(10):1274-83. PubMed ID: 22543588
    [Abstract] [Full Text] [Related]

  • 4. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
    Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK.
    J Natl Cancer Inst; 2004 Oct 20; 96(20):1536-48. PubMed ID: 15494604
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradation.
    Oh SH, Whang YM, Min HY, Han SH, Kang JH, Song KH, Glisson BS, Kim YH, Lee HY.
    Int J Cancer; 2012 Nov 15; 131(10):2253-63. PubMed ID: 22362554
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.
    Kim JH, Choi DS, Lee OH, Oh SH, Lippman SM, Lee HY.
    Blood; 2011 Sep 01; 118(9):2622-31. PubMed ID: 21551235
    [Abstract] [Full Text] [Related]

  • 7. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
    Yang J, Qin G, Luo M, Chen J, Zhang Q, Li L, Pan L, Qin S.
    Cell Death Dis; 2015 Jul 23; 6(7):e1829. PubMed ID: 26203858
    [Abstract] [Full Text] [Related]

  • 8. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK, Kim SY, Hwang PH, Kim CY, Yang DH, Oh Y, Lee DY.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):760-7. PubMed ID: 15809062
    [Abstract] [Full Text] [Related]

  • 9. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY, Oh SH, Suh YA, Baek JH, Papadimitrakopoulou V, Huang S, Hong WK.
    Clin Cancer Res; 2005 Aug 15; 11(16):6065-74. PubMed ID: 16115952
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U, Fleming J, Verma PS, Hogan KA, Desury G, Cohick WS.
    Endocrinology; 2004 Sep 15; 145(9):4213-21. PubMed ID: 15192040
    [Abstract] [Full Text] [Related]

  • 11. Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.
    Kim WY, Kim MJ, Moon H, Yuan P, Kim JS, Woo JK, Zhang G, Suh YA, Feng L, Behrens C, Van Pelt CS, Kang H, Lee JJ, Hong WK, Wistuba II, Lee HY.
    Endocrinology; 2011 Jun 15; 152(6):2164-73. PubMed ID: 21447628
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
    Coleman KL, Chiaramonti M, Haddad B, Ranzenberger R, Henning H, Al Khashali H, Ray R, Darweesh B, Guthrie J, Heyl D, Evans HG.
    Cells; 2023 Jan 25; 12(3):. PubMed ID: 36766747
    [Abstract] [Full Text] [Related]

  • 13. Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.
    Pernía O, Belda-Iniesta C, Pulido V, Cortes-Sempere M, Rodriguez C, Vera O, Soto J, Jiménez J, Taus A, Rojo F, Arriola E, Rovira A, Albanell J, Macías MT, de Castro J, Perona R, Ibañez de Caceres I.
    Epigenetics; 2014 Nov 25; 9(11):1446-53. PubMed ID: 25482372
    [Abstract] [Full Text] [Related]

  • 14. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.
    Guix M, Faber AC, Wang SE, Olivares MG, Song Y, Qu S, Rinehart C, Seidel B, Yee D, Arteaga CL, Engelman JA.
    J Clin Invest; 2008 Jul 25; 118(7):2609-19. PubMed ID: 18568074
    [Abstract] [Full Text] [Related]

  • 15. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X, Wang Y, Jiang T, Cai W, Jin Y, Niu Y, Zhu H, Bu Y.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772705
    [Abstract] [Full Text] [Related]

  • 16. The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.
    Song KH, Kang JH, Woo JK, Nam JS, Min HY, Lee HY, Kim SY, Oh SH.
    BMC Cancer; 2014 Jan 20; 14():31. PubMed ID: 24438088
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.
    Chang YS, Wang L, Suh YA, Mao L, Karpen SJ, Khuri FR, Hong WK, Lee HY.
    Oncogene; 2004 Aug 26; 23(39):6569-80. PubMed ID: 15247904
    [Abstract] [Full Text] [Related]

  • 18. Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.
    Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C, Lee HY.
    Mol Cancer Ther; 2006 Nov 26; 5(11):2685-95. PubMed ID: 17121915
    [Abstract] [Full Text] [Related]

  • 19. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.
    Zhao FY, Han J, Chen XW, Wang J, Wang XD, Sun JG, Chen ZT.
    Int J Mol Med; 2016 Jul 26; 38(1):183-91. PubMed ID: 27177336
    [Abstract] [Full Text] [Related]

  • 20. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.
    Hochscheid R, Jaques G, Wegmann B.
    J Endocrinol; 2000 Sep 26; 166(3):553-63. PubMed ID: 10974650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.